Tagged Multiple Sclerosis

0

Healthcare companies pair up to work on digital solutions for schizophrenia and MS

A collaboration between healthcare solutions provider, Novartis, and Pear Therapeutics has been announced that aims to develop digital therapeutics for patients with schizophrenia and multiple sclerosis (MS). The companies will work together, drawing on Novartis’ expertise in biomedical research and clinical development and Pear Therapeutics’ experience in digital therapeutics design and implementation, to develop new treatments…

© 2018 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions